GNS Healthcare Blog

GNS Healthcare Blog

GNS Healthcare Primary Blog

By December 31, 1969

Moving the Needle with Real World Data: How Oncology is Leading the Way

The thought of gathering massive amounts of data, from claims to EHR to molecular and making it easily accessible for drug development research once seemed impossible, as did getting at previously 'undruggable' pathways that defied the effects of even the most innovative drugs.  Now, with the advent of immuno-oncology, the oncology field is poised to take advantage of these advances to enable the development of precise therapies that match the right drug to the right patient.

The recent GNS Precision Medicine Forum presented a panel of pharma industry experts leading the charge in using...

Read More

Follow the Tumor: How Oncology R&D is Leading the Charge in AI Implementation

In 2017, the American Cancer Society awarded $112 million for cancer research.[1] The National Institute of Health FY17 budget for cancer research was nearly $6 billion.[2]

Pharma companies are pouring billions of R&D dollars into developing new treatments for cancer and are looking for the best ways to maximize those investments. One of the, most effective research tools available and one increasingly leveraged by biopharma is artificial intelligence (AI), used to help unlock the complex mechanisms of cancer.

Oncology is an enormously complicated field, so it’s no surprise that...

Read More

Immunotherapy and AI: Advancing Our View of Cancer Treatment

Most allergy sufferers know that receiving a series of allergy shots can prevent sniffling, sneezing, and red eyes. But not everyone is aware of how it actually works. The shots contain a very small amount of the allergen, the thing that is causing the problem. While the allergen introduced into the system isn’t enough to cause sickness, it does set off an alarm telling the body’s immune system it’s time to get to work. Over time, the doses get larger and eventually help the body develop a tolerance to the allergen. In other words, the body becomes immune to the invader.

This concept is a...

Read More

Location, Location, Location: AI Identifies Tumor Sidedness as Key Indicator of Progression in Metastatic Colorectal Cancer

Location matters, especially when it comes to tumors in colon cancer. The issue of “sidedness” – whether tumors are located on the right or left side of the intestine – and what impact that has on the progression of metastatic colorectal cancer (CRC) has been a topic of discussion in the clinical community for several years. A complete understanding of sidedness has not been well understood by researchers and clinicians. Is sidedness an independent driver, confounded by other factors, or a simply a surrogate for other determinants?  By leveraging artificial intelligence (AI) and causal...

Read More

Subscribe to the GNS Newsletter

Recent Posts:

Twitter